chrX-68839969-C-T
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The NM_004429.5(EFNB1):c.509C>T(p.Ala170Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.001 in 1,210,488 control chromosomes in the GnomAD database, including 12 homozygotes. There are 339 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_004429.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00535 AC: 601AN: 112429Hom.: 4 Cov.: 24 AF XY: 0.00471 AC XY: 163AN XY: 34587
GnomAD3 exomes AF: 0.00151 AC: 275AN: 182215Hom.: 3 AF XY: 0.00108 AC XY: 72AN XY: 66807
GnomAD4 exome AF: 0.000557 AC: 612AN: 1098006Hom.: 8 Cov.: 32 AF XY: 0.000484 AC XY: 176AN XY: 363366
GnomAD4 genome AF: 0.00533 AC: 600AN: 112482Hom.: 4 Cov.: 24 AF XY: 0.00470 AC XY: 163AN XY: 34650
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jan 09, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 25, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 19, 2020 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at